[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 65, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 60, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.39, "open": 1.39, "dayLow": 1.36, "dayHigh": 1.4, "regularMarketPreviousClose": 1.39, "regularMarketOpen": 1.39, "regularMarketDayLow": 1.36, "regularMarketDayHigh": 1.4, "payoutRatio": 0.0, "beta": -1.828, "trailingPE": 0.015308369, "forwardPE": -0.52851707, "volume": 35826, "regularMarketVolume": 35826, "averageVolume": 164019, "averageVolume10days": 70790, "averageDailyVolume10Day": 70790, "bid": 1.32, "ask": 1.43, "bidSize": 1, "askSize": 1, "marketCap": 3496267, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 30.43, "fiftyDayAverage": 1.536, "twoHundredDayAverage": 5.79016, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -1529726, "profitMargins": 0.0, "floatShares": 2514701, "sharesOutstanding": 2515300, "sharesShort": 90668, "sharesShortPriorMonth": 128877, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.036, "heldPercentInsiders": 0.00018999999, "heldPercentInstitutions": 0.0078100003, "shortRatio": 0.39, "shortPercentOfFloat": 0.0361, "impliedSharesOutstanding": 2515300, "bookValue": 1.331, "priceToBook": 1.0443276, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11919000, "trailingEps": 90.8, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.153, "52WeekChange": -0.8380897, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 1.39, "targetHighPrice": 34.0, "targetLowPrice": 10.0, "targetMeanPrice": 22.0, "targetMedianPrice": 22.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5122000, "totalCashPerShare": 2.036, "ebitda": -10027000, "totalDebt": 96000, "quickRatio": 2.218, "currentRatio": 2.415, "debtToEquity": 2.89, "returnOnAssets": -0.98684, "returnOnEquity": -2.48924, "freeCashflow": -5767375, "operatingCashflow": -9169000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.39, "postMarketChange": 0.0, "regularMarketChange": 0.0, "regularMarketDayRange": "1.36 - 1.4", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 164019, "fiftyTwoWeekLowChange": 0.28999996, "fiftyTwoWeekLowChangePercent": 0.26363632, "fiftyTwoWeekRange": "1.1 - 30.43", "fiftyTwoWeekHighChange": -29.04, "fiftyTwoWeekHighChangePercent": -0.9543214, "fiftyTwoWeekChangePercent": -83.80897, "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1756498204, "regularMarketTime": 1756497600, "exchange": "NCM", "messageBoardId": "finmb_136941170", "shortName": "GRI Bio, Inc.", "longName": "GRI Bio, Inc.", "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 90.8, "epsForward": -2.63, "epsCurrentYear": -4.045, "priceEpsCurrentYear": -0.3436341, "fiftyDayAverageChange": -0.14600003, "fiftyDayAverageChangePercent": -0.0950521, "twoHundredDayAverageChange": -4.4001603, "twoHundredDayAverageChangePercent": -0.7599376, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Vallon Pharmaceuticals, Inc.", "nameChangeDate": "2025-08-29", "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 1.39, "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]